probiotics

Evonik and Vland Biotech Begin Joint Venture

Evonik Vland Biotech, a new joint venture between Evonik China and Shandong Vland Biotech, began operations on January 1, 2024. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. The official opening took place in Qingdao on March 14.

News

DSM in Talks to Take Adare Biome

DSM is in exclusive talks with US CDMO Adare Pharma Solutions to buy Adare Biome, a French developer and manufacture of postbiotics, for €275 million.

News

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale

Top-Feature

Sasol

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Evonik Industries AG

probiotics

Evonik and Vland Biotech Begin Joint Venture

DSM in Talks to Take Adare Biome

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale

Top-Feature

Leading Transformation

Upcoming Virtual Events

Leading the way. Driving results.

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Anchored in Sustainability

Brenntag Downsizes Management Board, Retains Both Divisions